Pharmaceuticals: FDA labeling time line

Journal of Law, Medicine and Ethics 25 (1):75-76 (1996)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,296

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Pharmaceuticals: managing managed care and recent FDA responses.A. R. Ragade - 1997 - Journal of Law, Medicine and Ethics 26 (1):68-72.
RU 486, the FDA and Free Enterprise.Nancy L. Buc - 1992 - Journal of Law, Medicine and Ethics 20 (3):224-225.
RU 486, the FDA and Free Enterprise.Nancy L. Buc - 1992 - Journal of Law, Medicine and Ethics 20 (3):224-225.
Pharmaceuticals: manufacturers' price-fixing schemes challenged.S. Seitz - 1997 - Journal of Law, Medicine and Ethics 25 (4):325.
FDA to ban sales of dietary supplements containing ephedra.Amy M. Ling - 2004 - Journal of Law, Medicine and Ethics 32 (1):184.
The FDA: Is It Protecting the Public with One Hand Tied Behind Its Back?Roger S. Shedlin - 1992 - Journal of Law, Medicine and Ethics 20 (3):253-257.
The FDA: Is It Protecting the Public with One Hand Tied Behind Its Back?Roger S. Shedlin - 1992 - Journal of Law, Medicine and Ethics 20 (3):253-257.
Drug Labeling: FDA Requires New Label for Antibiotics to Prevent Overuse.Devesh Tiwary - 2003 - Journal of Law, Medicine and Ethics 31 (3):458-460.

Analytics

Added to PP
2014-04-01

Downloads
1 (#1,913,683)

6 months
5 (#710,311)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references